The contraction in valuation multiples appears to be a direct response to the instability in FFO generation observed over the last ten quarters. Investors should monitor whether the current implied cap rate adequately compensates for the capital-intensive nature of maintaining on-campus medical office assets in a high-rate environment.

The persistent negative margins suggest that the core business may be struggling to achieve the expected economies of scale post-merger. This trend indicates that organic growth is likely being offset by rising operating expenses and the high cost of maintaining specialized medical facilities.

The inability to consistently maintain a sustainable payout ratio indicates that the dividend may be at risk if FFO does not stabilize. Investors should be cautious, as the reliance on external capital to fund distributions during periods of negative AFFO is generally not a long-term viable strategy.

The low interest coverage ratios observed in several recent quarters indicate that the company's ability to service its debt obligations is currently constrained. This leverage profile may limit management's flexibility to pursue growth initiatives without further diluting existing shareholders through equity issuance.